Dr Lloyd Bernard Mandel, MD | |
588 Old Mount Holly Rd, Goose Creek, SC 29445-2814 | |
(843) 376-5595 | |
(843) 797-7432 |
Full Name | Dr Lloyd Bernard Mandel |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 57 Years |
Location | 588 Old Mount Holly Rd, Goose Creek, South Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225113178 | NPI | - | NPPES |
GP0504 | Medicaid | SC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0000X | Pain Medicine - Pain Medicine | 10054 (South Carolina) | Secondary |
208600000X | Surgery | 10054 (South Carolina) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pm Health Alliance, Llc | 0547526121 | 3 |
News Archive
MultiCell Technologies, Inc. is pleased to announce the signing of a new sponsored research agreement with Anand Ghanekar, M.D., Ph.D, of the University Health Network's Toronto General Hospital expanding the scope of the research project to evaluate MCT-485 in animal models for the treatment of primary liver cancer.
Transition Therapeutics Inc. today announced that its licensing partner, Elan Corporation, plc has commenced a Phase 2, placebo-controlled, safety and efficacy study of oral ELND005 as an adjunctive maintenance treatment in patients with Bipolar I Disorder (BPD 1) to delay the time to occurrence of mood episodes.
OSI Pharmaceuticals, Inc. will fully redeem on April 21, 2010 all of its remaining outstanding 3.25% Convertible Senior Subordinated Notes due 2023 pursuant to the terms of the indenture under which the Notes were issued in September 2003. The aggregate principal amount currently outstanding of the Notes is $60,467,000. The CUSIP number for these Notes is 671040 AD 5.
This week the WHO brought together lawmakers from across Southeast Asia in Bangkok "to discuss how to bolster their health systems back home," IRIN reports. Meeting participants were "called on to advocate the boosting of health spending, workforces and access to health care in their home countries in addition to drafting 'healthy public policies,' such as conducting health assessments before large infrastructural projects are undertaken," the news service writes.
› Verified 3 days ago
Entity Name | Pm Health Alliance, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1326590746 PECOS PAC ID: 0547526121 Enrollment ID: O20171115000656 |
News Archive
MultiCell Technologies, Inc. is pleased to announce the signing of a new sponsored research agreement with Anand Ghanekar, M.D., Ph.D, of the University Health Network's Toronto General Hospital expanding the scope of the research project to evaluate MCT-485 in animal models for the treatment of primary liver cancer.
Transition Therapeutics Inc. today announced that its licensing partner, Elan Corporation, plc has commenced a Phase 2, placebo-controlled, safety and efficacy study of oral ELND005 as an adjunctive maintenance treatment in patients with Bipolar I Disorder (BPD 1) to delay the time to occurrence of mood episodes.
OSI Pharmaceuticals, Inc. will fully redeem on April 21, 2010 all of its remaining outstanding 3.25% Convertible Senior Subordinated Notes due 2023 pursuant to the terms of the indenture under which the Notes were issued in September 2003. The aggregate principal amount currently outstanding of the Notes is $60,467,000. The CUSIP number for these Notes is 671040 AD 5.
This week the WHO brought together lawmakers from across Southeast Asia in Bangkok "to discuss how to bolster their health systems back home," IRIN reports. Meeting participants were "called on to advocate the boosting of health spending, workforces and access to health care in their home countries in addition to drafting 'healthy public policies,' such as conducting health assessments before large infrastructural projects are undertaken," the news service writes.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Lloyd Bernard Mandel, MD 588 Old Mount Holly Rd, Goose Creek, SC 29445-2814 Ph: (843) 376-5595 | Dr Lloyd Bernard Mandel, MD 588 Old Mount Holly Rd, Goose Creek, SC 29445-2814 Ph: (843) 376-5595 |
News Archive
MultiCell Technologies, Inc. is pleased to announce the signing of a new sponsored research agreement with Anand Ghanekar, M.D., Ph.D, of the University Health Network's Toronto General Hospital expanding the scope of the research project to evaluate MCT-485 in animal models for the treatment of primary liver cancer.
Transition Therapeutics Inc. today announced that its licensing partner, Elan Corporation, plc has commenced a Phase 2, placebo-controlled, safety and efficacy study of oral ELND005 as an adjunctive maintenance treatment in patients with Bipolar I Disorder (BPD 1) to delay the time to occurrence of mood episodes.
OSI Pharmaceuticals, Inc. will fully redeem on April 21, 2010 all of its remaining outstanding 3.25% Convertible Senior Subordinated Notes due 2023 pursuant to the terms of the indenture under which the Notes were issued in September 2003. The aggregate principal amount currently outstanding of the Notes is $60,467,000. The CUSIP number for these Notes is 671040 AD 5.
This week the WHO brought together lawmakers from across Southeast Asia in Bangkok "to discuss how to bolster their health systems back home," IRIN reports. Meeting participants were "called on to advocate the boosting of health spending, workforces and access to health care in their home countries in addition to drafting 'healthy public policies,' such as conducting health assessments before large infrastructural projects are undertaken," the news service writes.
› Verified 3 days ago